We maintain our BUY recommendation on RHB Bank with a revised fair value of RM6.80/share (previously: RM6.90/share). We peg the stock to FY22 P/BV of 0.9x supported by a lower ROE of 10.0%. We fine-tune our FY21/22/23 earnings by -1.8%/-2.2%/-2.4% after lowering our non-interest income (NOII) estimates.
RHB Bank recorded higher core earnings of RM701mil (+7.4%QoQ) for 2Q21 underpinned by higher total income, lower operating expenses (opex) partially offset by higher provisions.
6M21 underlying net profit came in at RM1.35bil (+5.5% YoY) supported by stronger net interest income (NII) partially offset by lower non-interest income (NOII), higher opex and provisions. Cumulative earnings were within expectations, making up 51.9% and 54.5% of our and consensus estimate respectively.
The group’s loan growth decelerated to 5.7% YoY in 2Q21 (1Q21: 6.8% YoY).
Loan expansion was supported by mortgages, auto finance, SME loans and growth of overseas loans (mainly Singapore). Corporate loan growth remained muted due to repayments.
Domestic loans grew 4.1% YoY ahead of the industry’s +3.4% YoY.
NIM declined marginally by 2bps QoQ to 2.15% in 2Q21.
Based on underlying total income (excluding mod loss), JAW was positive of 0.5% YoY for 6M21.
2Q21 credit cost was higher at 0.46% with additional provisions (management overlays) of RM161mil booked. 6M21 credit cost of 0.42% was slightly above management’s guidance of 0.40% for FY21.
The group’s GIL ratio improved slightly to 1.63% in 2Q21.
An interim dividend of 15 sen/share has been declared, representing a payout of 45.1%, higher than FY20’s p10 sen/share. The dividend comprises 5.0 sen cash and 10 sen electable under the DRP.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....